Schering-Plough MRK

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. New Morningstar Analyst Report for Bayer AG

      Stock Reports

      Thu, 18 Sep 2014

      largely based on its average use of capital. The biggest move the company made over the past decade was the acquisition of Schering in 2006, which we view as neutral with the benefits largely equaling the price paid for the company. Further, the acquisition

    2. New Morningstar Analyst Report for Celgene Corp

      Stock Reports

      Tue, 29 Jul 2014

      and we particularly applaud the recent addition of directors with relevant experience, including Pharmacia and Schering - Plough veteran Carrie Cox and City of Hope CEO Michael Friedman. In addition, we think the firm's acquisition strategy

    3. ‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush


      Fri, 30 May 2014

      background or infrastructure. Merck came to own the consumer products ..... after its 2009 acquisition of Schering - Plough . Back then, Merck faced patent expirations on major ..... asthma drug Singulair — and Schering - Plough had a relatively stronger branded

    4. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat


      Wed, 7 May 2014

      bottom line, Merck has been cutting ..... merger with Schering - Plough , which Merck ..... Standard, as Merck has shown reasonable ..... purchase of Schering - Plough at a fair price ..... Further, Merck 's acquisition of Schering - Plough should yield

    5. New Morningstar Analyst Report for Forest Laboratories, Inc.

      Stock Reports

      Wed, 8 Jan 2014

      Saunders brings a wide range of experience from his CEO position at Bausch & Lomb and his years as an executive at Schering Plough . We think his extensive experience in the pharmaceutical business outside of primary care will actually be a positive

    6. Stockland Bolsters Balance Sheet Before Escalating Investment in Retail


      Wed, 22 May 2013

      Stockland SGP raised AUD 400 million of additional equity via an institutional placement at AUD 3.88 per security, representing a 2.5

    7. Stockland's Revised Strategy Sees Rebirth of Industrial


      Wed, 15 May 2013

      At the third-quarter update Stockland SGP guided fiscal 2013 earnings per share (EPS) to be down 25% on fiscal 2012. The downgrade to prior guidance for EPS to fall

    8. Stockland's Residential Impairment Overshadows Resilient Commercial Property Result in First Half


      Wed, 13 Feb 2013

      Stockland's SGP first-half fiscal 2013 normalised operating profit fell by 28% to AUD 255 million, largely due to a change to accounting treatment of interest capitalised into residential development. Stockland also impaired inventory held on balance sheet, resulting in a AUD 318 million writedown ...

    9. Lower Developer Margins Expected for Stockland Following Review of Capitalised Interest


      Tue, 22 Jan 2013

      Stockland SGP is undertaking a review of its capitalised interest policy following an escalation in the level of capitalised interest on the

    10. What Next For The Euro-Zone?


      Fri, 6 Jul 2012

      approved the Stability and Growth Pact ( SGP ) in 1997. This called for fiscal monitoring ..... behind Maastricht and especially behind the SGP was “don’t saddle the prudent members ..... Meanwhile, it quickly became apparent that the SGP was unenforceable – largely because the

    « Prev12345Next »
    Content Partners